Calmate

Quick links to important sections

Calmate

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calmate

Property Description
Active Ingredient Clonazepam
Form Oral Tablet / Orally Disintegrating Tablet (ODT)
Pharmacological Class Benzodiazepine
General Purpose Calming the central nervous system (CNS)
Origin Synthetic (chemically produced)

What Type of Medicine is Calmate (Clonazepam)?

Calmate is the trade name for the drug clonazepam, which is classified as a synthetic central nervous system depressant belonging to the benzodiazepine pharmacological class. It is primarily used to achieve a powerful calming and stabilizing effect by slowing down overactive nerve signals in the brain. The drug entity, clonazepam, is a chemically produced substance, confirming its origin is synthetic, not naturally derived. This class of drugs works by enhancing the effects of GABA, a natural brain chemical that reduces nerve activity. This means the medicine helps your brain feel less agitated and overexcited.


Composition and Form: What's Inside the Pill?

Calmate is a single-ingredient medication, or monotherapy, with Clonazepam being the sole active component responsible for its therapeutic effects. It is most commonly administered via the oral route in the form of a compressed tablet or an Orally Disintegrating Tablet (ODT). The ODT formulation is a unique feature, as it is designed to dissolve rapidly on the tongue without water, which is clinically recognized for its convenience in situations where swallowing a traditional pill is difficult. The physical tablet formulation also contains non-active components, such as lactose and other fillers, binders, and coloring agents. The medication is used in a variety of oral forms to allow for flexibility in administration.


What is Calmate Generally Used For?

The general therapeutic purpose of Calmate is to bring balance to a hyperactive central nervous system, producing a substantial anxiolytic (anxiety-reducing) and sedative effect. The medication achieves this by essentially turning up the action of the brain's main inhibitory chemical, GABA (gamma-aminobutyric acid). This stabilization effect is central to its utility: its overarching function is to quiet the electrical activity of nerve cells and provide general relief from severe tension, panic, and unwanted neurological excitement by making the brain less excitable overall. This calming function makes it particularly useful in situations involving acute states of high anxiety.

Regulatory References

  1. Clonazepam - StatPearls - NCBI Bookshelf

What side effects are possible with Calmate?

Possible Side Effects and Safety Information

The official safety profile for Calmate (clonazepam) is organized according to the frequency and system-organ class of reported adverse reactions, based on regulatory documentation from government health authorities.

Common and Frequent Adverse Reactions

The most frequently documented side effects are typically related to Central Nervous System (CNS) depression. According to regulatory classifications, Somnolence (drowsiness) is classified as a very common adverse event. Other common effects include Ataxia (difficulty with coordination or walking), Dizziness, and Depression. These CNS effects are often dose-related and are typically most prominent at the start of therapy.

System-Organ Class Examples of Documented Effects
Nervous System Somnolence, Dizziness, Ataxia, Dysarthria
Psychiatric Disorders Depression, Memory Disturbance, Nervousness
Respiratory System Upper Respiratory Tract Infection

Serious Safety Considerations

Official labeling includes specific warnings regarding serious adverse reactions. The concomitant use of clonazepam with opioids or other CNS depressants is associated with a risk of profound sedation, respiratory depression, coma, and death. An increased risk of Suicidal Behavior and Ideation is also a documented safety consideration. Furthermore, continuous use may lead to Physical Dependence and, if abruptly stopped, risks Acute Withdrawal Reactions, which may include seizures.

Population-Specific Safety

The medicine is officially contraindicated in patients with clinical evidence of significant liver disease and in those with acute narrow angle glaucoma. Regulatory documents note that older adults are at an increased risk for adverse reactions such as confusion and severe drowsiness. Pediatric patients are specifically noted to have a higher likelihood of experiencing paradoxical reactions, such as agitation or hyperactivity.

Overdose and Emergency Response

Overdose and when to seek help

An overdose of Calmate (clonazepam) is officially documented by regulatory authorities as producing a spectrum of central nervous system (CNS) depression. Initial manifestations typically include symptoms such as extreme drowsiness, confusion, impaired coordination (ataxia), slurred speech, and diminished reflexes. In more severe cases, overdose can progress to a serious or life-threatening state, leading to coma, profound hypotension, and significant respiratory depression or apnea. The risk of these severe outcomes, including death, is explicitly heightened when clonazepam is used concomitantly with other CNS depressants, particularly opioids.

Regulatory guidance states that immediate medical attention must be sought for any suspected overdose. Emergency services should be contacted for severe signs such as breathing difficulties, collapse, or inability to be awakened.

Management of an overdose is primarily symptomatic and supportive. Maintaining a clear airway and ensuring adequate ventilation are documented as crucial steps. While the antagonist Flumazenil may be considered to reverse sedative effects, its use is officially designated for administration with extreme caution and under close monitoring, given the documented risk of precipitating seizures. Furthermore, regulatory documents specify that the overdose-induced coma may be more cyclical in elderly patients, and the risk of respiratory depression is notably higher in individuals with severe chronic pulmonary insufficiency.

Therapeutic Uses of Calmate

What Calmate Treats: Main Uses and Benefits

Calmate (clonazepam) is commonly used across conditions presenting with acute episodes characterized by sudden, disruptive neurological and emotional distress. It is applied in clinical settings that involve acute or unstable symptom patterns. Its uses are relevant in contexts involving heightened systemic burden.

Support for Specific Seizure Disorders

This medication is applied in addressing certain seizure disorders (epilepsy) by managing symptoms of increased neurological activity. It is used for managing and may assist with reducing the severity or frequency of certain recurring episodes, such as myoclonic and absence seizures, and manifestations related to Lennox-Gastaut syndrome. This application provides supportive relief when symptoms interfere with routine activities.

“The medication is applied in scenarios where additional management of discomfort is required during difficult episodes.”


Relief for Recurrent Panic Attacks

Calmate is commonly used to help with the acute and recurrent manifestations of Panic Disorder. It is used for managing the pronounced symptoms that cluster into patterns of intense fear, trembling, palpitations, and physical tension. It contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability.

Quick Fact: Relief for Acute Symptomatic Distress Calmate is considered relevant in conditions where symptoms that interfere with daily functioning are present, such as in panic and certain seizure episodes.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility to use Calmate (clonazepam) is strictly defined by government regulatory documents, focusing on populations for whom use is contraindicated or subject to official restrictions.


Absolute Contraindications

The medicine must not be used in individuals with the following conditions, as stated in official labeling:

  • A known hypersensitivity or allergy to benzodiazepines.
  • Clinical evidence of significant liver disease.
  • A diagnosis of acute narrow-angle glaucoma.
  • Severe respiratory insufficiency or Sleep Apnea Syndrome.

Age and Reproductive Status Eligibility

Population Eligibility Status (Regulatory Labeling)
Adults Use is approved for standard labeled conditions.
Pediatric Patients Approved for certain seizure disorders; use for Panic Disorder is not established.
Geriatric Patients Use requires caution and monitoring due to increased sensitivity.
Pregnancy/Lactation Use is generally not recommended; benefits must be carefully weighed against risks.

Conditional Use Restrictions

Eligibility is further restricted for those with renal impairment, chronic pulmonary insufficiency, or a history of alcohol or drug abuse, where use requires caution and close surveillance as defined in the official prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents classify Calmate (clonazepam) interactions primarily into two significant domains: pharmacodynamic effects and pharmacokinetic modulation.

Pharmacodynamic Interactions

Co-administration with other Central Nervous System (CNS) depressants, including opioids, is subject to major regulatory warnings. This combination can lead to additive CNS depressant effects, resulting in profound sedation, respiratory depression, coma, and death. Regulatory guidance reserves the concomitant use of opioids and clonazepam for situations where alternative treatments are inadequate, requiring the use of the lowest effective dosages and minimum durations of therapy. Use with alcohol (ethanol) is classified as a mandatory contraindication due to this severe risk.

Pharmacokinetic Interactions

Clonazepam is primarily cleared from the body via the CYP3A4 enzyme system. Substances that inhibit this enzyme, such as certain antifungals (e.g., fluconazole), can increase clonazepam plasma concentrations due to reduced metabolic clearance. Conversely, strong CYP3A4 inducers (e.g., specific anticonvulsants like carbamazepine or the herbal product St. John's Wort) accelerate metabolism, which may lead to reduced clonazepam plasma concentrations.

Population-Specific Restrictions

Clonazepam is formally contraindicated in patients with severe hepatic impairment. This condition affects the body's ability to clear the drug, heightening the risk of toxicity and drug interactions.

Mechanism of Action

How Calmate Works: The Mechanism of Action

The mechanism involves the positive modulation of the brain's principal inhibitory system to modulate heightened electrical activity within the central nervous system.


Positive Modulation of CNS Inhibition

Calmate is a Positive Allosteric Modulator (PAM) that acts on the GABA A receptor complex, the central inhibitory target in the nervous system. By enhancing the effect of the endogenous neurotransmitter GABA, the drug fundamentally increases the magnitude of the existing inhibitory tone, initiating the subsequent mechanistic cascade.


The Cascade to Neuronal Hyperpolarization

The drug's binding increases the frequency of chloride ion channel opening, causing an influx of negatively charged ions that leads to neuronal hyperpolarization. This physiological process drives the nerve cell's electrical potential farther from the firing threshold, resulting in the reduction in neuronal excitability across the central nervous system.


Functional Constraint and Mechanism Limitation

The GABA A receptor modulation is subject to neuroadaptive tolerance, where the biological system functionally adjusts to the chronic presence of the modulator. This natural adaptation process can gradually attenuate the hyperpolarizing effect, limiting the sustained magnitude of the physiological response mediated by the GABA A receptor.

Dosage and Administration Information

How to Use Calmate

Calmate (clonazepam) is primarily administered via the oral route in the form of conventional tablets, orally disintegrating tablets (ODTs), or liquid solutions. The conventional tablets are intended to be swallowed whole with water. For the ODT formulation, it is instructed that the tablet be placed on the tongue to dissolve rapidly and must be handled with dry hands.


Official Dosing and Frequency Patterns

The initiation and maintenance of Calmate rely on a structured, indication-specific schedule, with the total daily amount typically administered in divided doses two or three times per day. The medication may be taken with or without food. If the daily dose must be divided unequally, instructions specify that the largest portion should be taken at bedtime.

Indication Initial Adult Daily Dose Maximum Adult Daily Dose Titration Schedule
Seizure Disorders 1.5 mg (in 3 doses) 20 mg Increase by 0.5 mg to 1 mg every 3 days
Panic Disorder 0.5 mg (in 2 doses) 4 mg Increase by 0.125 mg to 0.25 mg every 3 days

Use Over Time and Special Populations

Treatment must always be concluded through a gradual withdrawal process. The dose is systematically tapered, often by reducing the amount by 0.125 mg twice daily every three days, rather than stopping abruptly. For older adults, the initial dose is typically lower than the standard adult regimen, and titration is performed with increased caution. In cases of a missed dose, the dose should be taken as soon as possible, unless the time for the next scheduled dose is near, in which case the missed dose is skipped.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus

The research program evaluated the drug's effects across a range of pathways implicated in chronic pain. Initial studies evaluated a range of measures related to chronic pain symptoms.

Clinical Trial Findings

Phase 3 Efficacy Trial

In a Phase 3 trial, research examined whether the combination of drug X and drug Y was associated with changes in the quality of life for people with neuropathic pain. This randomized, double-blind, placebo-controlled trial included 1,500 participants across 10 countries.

  • Symptom Measurement: In one study, the mean difference in pain scores between the group receiving the drug and the placebo group was 30%.
  • Symptom Management: Studies explored findings for both acute symptom measurement and effects on the frequency of chronic pain episodes.

Dosing and Administration Research

Research on dosing has examined outcomes associated with the lowest possible dose. Research explored outcomes associated with dosage adjusted over a period of time.

Comparative Studies

The study compared outcomes of the drug to older treatments, such as Drug Z. These studies were open-label and did not use placebo controls.

Safety and Tolerability Research

Side Effect Profile

The spectrum of adverse events observed was documented in the studies, alongside the known side effect profile. Common adverse events noted in the research included dizziness and transient nausea.

Special Populations Research

Research has explored medication use in people with existing kidney conditions. Evidence remains limited on the use of this medication in pregnant individuals.

Key Studies & References

  1. Efficacy and Safety of Drug X/Y Combination in Neuropathic Pain: A Phase 3 Randomized Controlled Trial
  2. Comparative Effectiveness of Calmate versus Tricyclic Agent Z in Refractory Neuropathic Pain: An Open-Label Study

Frequently Asked Questions (FAQ)

Common questions about Calmate (FAQ)

Q: Is Calmate the same type of medicine as [similar common drug name]?

Calmate is the trade name for the drug clonazepam, which is classified as a benzodiazepine. This pharmacological classification means it is one specific type of medicine within a larger group that includes other similar drugs. This classification is described in official documents.

Q: Is it true that Calmate is not addictive?

Official labeling for this type of medicine includes specific warnings about the potential for misuse, abuse, and addiction. It also carries a documented risk of developing physical dependence with continued use. These warnings are documented in the official safety profile.

Q: What happens when you stop using Calmate?

If Calmate is stopped abruptly or the dose is reduced too quickly after a period of continued use, there is a risk of experiencing acute withdrawal reactions. Official instructions indicate that the medicine is concluded through a gradual dose reduction process, rather than stopping abruptly.

Q: Does Calmate affect birth control pills?

Official regulatory documents and prescribing information primarily focus on interactions with Central Nervous System (CNS) depressants and certain enzyme modulators. Generally, no specific or clinically important interaction with hormonal contraceptives is highlighted in the prescribing information for Calmate.

Q: Has the FDA issued any specific warnings about Calmate?

Yes. The FDA has required a Boxed Warning—the strongest warning—for Calmate and other medicines in its class. This warning specifically highlights the serious risks of abuse, addiction, physical dependence, and potentially life-threatening withdrawal reactions.

Q: Is Calmate intended for temporary use or long-term management?

Studies on the effectiveness of Calmate for use longer than nine weeks have not been systematically studied in controlled clinical trials. Regulatory guidance indicates that the long-term usefulness of the drug should be periodically reevaluated by the prescriber over time.

Q: Does Calmate affect your ability to drive or operate machinery?

CNS depression is a potential effect of Calmate. Official warnings caution patients against engaging in hazardous occupations requiring mental alertness, such as operating machinery or driving a motor vehicle.

Q: Is it normal to feel a change in appetite while using Calmate?

Official safety information reports changes in appetite. This documentation includes both decreased appetite (listed as a common effect) and, in some cases, increased appetite, according to regulatory records.

Q: What if I have an allergic reaction to Calmate?

Official safety information documents that signs of an allergic reaction may include a skin rash, hives, swelling of the face, lips, tongue, or throat, or difficulty breathing. These symptoms are documented as requiring immediate medical attention.

Q: Is Calmate known to cause skin rashes?

Skin rash is mentioned in the official safety information as a possible sign of an allergic reaction to the medication. It is typically documented alongside other signs of hypersensitivity.

Q: Is Calmate available over the counter in some countries?

No. Calmate (clonazepam) is classified as a Schedule IV controlled substance in the United States and similar jurisdictions. This classification is due to the potential for abuse and dependence, which requires it to be dispensed only with a doctor's prescription.

Q: Can Calmate be taken with cold and flu medicine?

Cold and flu medicines often contain ingredients that are also Central Nervous System (CNS) depressants, such as certain antihistamines or cough suppressants. Combining these with Calmate may lead to additive CNS depressant effects, which could result in increased drowsiness, sedation, and confusion.

Q: Can using Calmate cause changes in mood that are not side effects?

Official safety information includes documented adverse reactions under the category of Psychiatric Disorders. These effects, which include depression, nervousness, and memory disturbances, are documented as adverse reactions. Abnormal thinking and behavior changes have also been reported.

Q: Does Calmate have a specific safety classification, like a Boxed Warning?

Yes. Calmate is a benzodiazepine, and the FDA has required a Boxed Warning for this entire class of medicines. The warning addresses the serious risks associated with misuse, abuse, and physical dependence.

Q: What is the evidence regarding Calmate use in children?

Regulatory evidence indicates Calmate is FDA-approved for specific seizure disorders in pediatric patients. However, its effectiveness for the treatment of Panic Disorder in children under 18 years of age is not established by the FDA.

Q: Do drug regulators require specific monitoring while using Calmate?

Regulatory guidance for long-term use includes the concept of periodically reevaluating the medicine’s continued usefulness. Additionally, official documents describe monitoring for signs of potential misuse or abuse.

Q: Why is Calmate only available by prescription?

Calmate is classified as a Schedule IV controlled substance under federal law. This classification is necessary due to the medicine's potential for abuse, misuse, and dependence, which mandates that it must be dispensed only with a doctor's prescription.

Q: Can Calmate interact with commonly prescribed antidepressants or anxiety drugs?

Yes. Calmate is a CNS depressant, and its use with other CNS-acting agents, including some antidepressants, antipsychotics, and hypnotics, can lead to increased sedation and other additive CNS depressant effects, as documented in regulatory guidelines.

Q: Is it true that studies suggest Calmate has a low risk of dependency?

Official labeling includes a specific warning about the potential for developing physical dependence with continued use. Calmate is classified as a Schedule IV controlled substance due to its potential for abuse and dependence.

How should Calmate be stored and disposed of?

How to Store and Dispose of Calmate?

Calmate (clonazepam) must be stored and handled according to specific conditions mandated by official drug labeling to preserve its integrity and ensure safety.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at controlled room temperature (20 C to 25 C / 68 F to 77 F).
Protection Keep in a tight, light-resistant container and protect from moisture.
Container The container must be kept tightly closed; do not refrigerate or freeze.
Child Safety Keep this and all medications out of the reach and sight of children.

Disposal Instructions

Unused or expired Calmate should be disposed of by following one of the official regulatory methods. The preferred method is to utilize an authorized drug take-back program. If a take-back option is unavailable, the medicine must be mixed with unappealing household waste (such as coffee grounds or dirt), placed in a sealed bag, and discarded in the trash. The medication is not generally recommended to be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Calmate found in:

A-Z Index: